• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Observation of the Curative Effect of the Dexamethasone Vitreous Cavity Implant for the Treatment of Irvine-Gass Syndrome
CONCLUSION: The dexamethasone vitreous cavity implant (Ozurdex) is a safe and effective treatment, which can effectively improve patient's visual acuity and reduce macular edema associated with cataract surgery.PMID:37711084 | DOI:10.3967/bes2023.084
Source: Biomedical and Environmental Sciences : BES - September 15, 2023 Category: Biomedical Science Authors: Yu Mao Li Qin Gao Li Yun Jia Si Meng Hou Yuan Yuan Xiao Xi Wen Ji Shuang Wang Source Type: research

Corticosteroid implants for chronic non-infectious uveitis
CONCLUSIONS: Our confidence is limited that local corticosteroid implants are superior to sham therapy or standard-of-care therapy in reducing the risk of uveitis recurrence. We demonstrated different effectiveness on BCVA relative to comparators in people with non-infectious uveitis. Nevertheless, the evidence suggests that these implants may increase the risk of cataract progression and IOP elevation, which will require interventions over time. To better understand the efficacy and safety profiles of corticosteroid implants, we need future trials that examine implants of different doses, used for different durations. The...
Source: Cochrane Database of Systematic Reviews - August 29, 2023 Category: General Medicine Authors: Amit Reddy Su-Hsun Liu Christopher J Brady Pamela C Sieving Alan G Palestine Source Type: research

Changes in the uninjected contralateral eye after intravitreal brolucizumab for exudative age-related macular degeneration
CONCLUSIONS: Although contralateral retinal changes have been described for many other vascular endothelial growth factor inhibitors, there is little evidence for brolucizumab. We describe a repeated dose- and time-related effect on the uninjected eye in a case of nAMD.PMID:37424299 | DOI:10.1177/11206721231187429
Source: European Journal of Ophthalmology - July 10, 2023 Category: Opthalmology Authors: Paolo Mora Carlo Bellucci Lorenzo M Radice Francesca Manzotti Stefano Gandolfi Source Type: research

The efficacy of different anti-vascular endothelial growth factor agents, and dexamethasone implant therapy in patients with serous retinal detachment caused by Irvine-Gass syndrome
CONCLUSION: All intravitreal agents were effective in terms of visual results in the SRD patients; however, eyes treated with IVA and IVDI required fewer injections, as compared to the eyes treated with IVB and IVR. Furthermore, SRD entirely resolved in all eyes in the IVA group at the final follow-up visit.PMID:37408434 | DOI:10.1177/11206721231185909
Source: European Journal of Ophthalmology - July 6, 2023 Category: Opthalmology Authors: Bu ğra Karasu Enes Kesim Ali R ıza Cenk Celebi Source Type: research

A case of recurring acute exudative polymorphous vitelliform maculopathy successfully treated with intravitreal Ozurdex injection
CONCLUSION: Our case demonstrates clinical and imaging findings consistent with recurrence of AEPVM with CMO that has been successfully treated with Ozurdex®.PMID:37350018 | DOI:10.1177/11206721231178559
Source: European Journal of Ophthalmology - June 23, 2023 Category: Opthalmology Authors: Vaishali Lodhia Anthony G Robson Shaheeni Khoda Hanbin Lee Edward Hughes Source Type: research

Pages: 1  2  3  4  5  6  7  8